Search research articles
Contact Us
Filters
Showing results (411-420 of 422) with videos related to
Page
of 43
Sort By:
International Journal of Epidemiology
|
October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R Cerhan, Brian K Link, Thomas M Habermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
Matthew J Maurer, Hervé Ghesquières, Jean-Philippe Jais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
Matthew J Maurer, Ivana N M Micallef, James R Cerhan, et al.
Experimental Hematology & Oncology
|
June 23, 2025
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
Rachel M Hurley, Jill M Wagner, Arun Kanakkanthara, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
The American Journal of Cardiology
|
December 29, 2014
Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States
Vikas Singh, Nileshkumar J Patel, Apurva O Badheka, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
Matthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Immunity
|
November 25, 2025
Topography of the HLA-A protein enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients
John T Killian, R Glenn King, Aaron C K Lucander, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2023
HLA topography enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients
John T Killian, R Glenn King, Aaron C K Lucander, et al.
Page
of 43
Search research articles
Search
Showing results (411-420 of 422) with videos related to
Sort By:
Page
of 43
International Journal of Epidemiology
|
October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R Cerhan, Brian K Link, Thomas M Habermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2014
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
Matthew J Maurer, Hervé Ghesquières, Jean-Philippe Jais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
Matthew J Maurer, Ivana N M Micallef, James R Cerhan, et al.
Experimental Hematology & Oncology
|
June 23, 2025
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
Rachel M Hurley, Jill M Wagner, Arun Kanakkanthara, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
The American Journal of Cardiology
|
December 29, 2014
Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States
Vikas Singh, Nileshkumar J Patel, Apurva O Badheka, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
Matthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
Immunity
|
November 25, 2025
Topography of the HLA-A protein enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients
John T Killian, R Glenn King, Aaron C K Lucander, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2023
HLA topography enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients
John T Killian, R Glenn King, Aaron C K Lucander, et al.
Page
of 43